ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Negative Impact of COVID-19 Associated Health System Shutdown on Patients Diagnosed With Colorectal Cancer: A Retrospective Study From a Large Tertiary Center in Ontario, Canada
This article has 7 authors:Reviewed by ScreenIT
-
Small-molecule ligands can inhibit −1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses
This article has 9 authors:Reviewed by Rapid Reviews Infectious Diseases, ScreenIT
-
Development and performance evaluation of a low-cost in-house rRT-PCR assay in Ecuador for the detection of SARS-CoV-2
This article has 8 authors:Reviewed by ScreenIT
-
COVID-19 & Mental Health: Impact on Working people and Students
This article has 3 authors:Reviewed by ScreenIT
-
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19
This article has 16 authors:Reviewed by ScreenIT
-
Llamanade: An open-source computational pipeline for robust nanobody humanization
This article has 4 authors:Reviewed by ScreenIT
-
On the Persistence of Mental Health Deterioration during the COVID-19 Pandemic by Sex and Ethnicity in the UK: Evidence from Understanding Society
This article has 2 authors:Reviewed by ScreenIT
-
Preliminary Analysis of Excess Mortality in India During the COVID-19 Pandemic
This article has 5 authors:Reviewed by ScreenIT
-
Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
This article has 17 authors:Reviewed by ScreenIT
-
Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine
This article has 11 authors:Reviewed by ScreenIT